Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

111, Inc. (YI) Market Cap & Valuation Ratios

111, Inc. (YI) has a market cap of $25.1M, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

Pharmaceutical Retailers · Healthcare
—
Price chart with a free account
Market cap
25.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
15 Dec, in 52 days

Peers

pharmaceutical retailers · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
YI0.0————-26%0.0%—
CVRX0.0—0.5——+12%-79%-371%
EYPT0.0————-95%—-275%
IRLA0.0———————
IBO0.0—878.5—-1.7%——-47%
RMTI0.0—0.4—5.5%-21%-7%-15%
NNOX0.0————+35%—-269%
DCGO0.0—0.0——-32%-62%-128%
CCM0.0————+20%-57%-25%
ACH0.0—0.76.1—-3%1%2%
PMI0.0—2.8——+41%-248%-531%
Median of these 10—0.66.11.9%+4%-59%-128%

.

Growth vs. price

each dot a company · hover or tap for values

111, Inc. — questions

What is 111, Inc.'s market cap?
$25.1M.

Every figure on this page comes from 111, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.